Aberrant cytokeratin 7 expression by hepatocytes can predict the ductopenia grade in primary biliary cholangitis
Authors:
Open Access
- 2 November 2022
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 22 (1) , 1-9
Abstract
Background: Aberrant cytokeratin 7 expression by hepatocytes (CK7+Hs) is the hallmark characteristic of cholestasis diseases, especially in ductopenia diseases such as primary biliary cholangitis (PBC). This study attempted to evaluate the differences and relationships between the clinical and histological features of aberrant cytokeratin 7 (CK7) expression by hepatocytes in PBC patients.Methods: The clinicopathological data of patients diagnosed with PBC at the Second Hospital of Nanjing between January 2016 and September 2018 were analysed with SPSS 20.0.Results: Eighty-nine PBC patients who underwent liver biopsy were enrolled in this study, and 15, 29 and 45 patients had aberrant CK7 expression by hepatocytes (CK7+Hs (2 +), CK7+Hs (1 +), and CK7−Hs, respectively). There were significant differences in TB, DB, ALP, TA, IgM, interface activity, and ductopenia grade between patients with CK7−Hs and CK7+Hs (2 +) (P < 0.05). The ductopenia grade was also significantly different between patients with CK7+Hs (2 +) and CK7+Hs (1 +) according to sex (P < 0.05). Upon merging the data of CK7+Hs (2 +) and CK7+Hs (1 +) into CK7+Hs, we found significant differences in AMA, AMA-M2, anti-gp210, TB, DB, ALP, TA, IgM, fibrosis, and ductopenia grade between CK7+Hs and CK7−Hs (P < 0.05). The odds ratios (ORs) (and 95% confidence intervals (CIs)) of CK7+Hs according to anti-gp210, ductopenia grade, and interface activity were 6.413 (95% CI 1.363–30.162), 4.145 (95% CI 1.898–9.052) and 3.247 (95% CI 1.556–6.775), respectively (P < 0.05). Spearman's rank correlation according to interface activity and ductopenia grade in patients with CK7+Hs (2 + , 1 + , 0) wasr = 0.359 (P = 0.001) andr = 0.396 (P < 0.001), respectively.Conclusion: CK7+Hs serves as a cholestasis index of PBC and are associated with the ductopenia grade and interface activity. Aberrant cytokeratin 7 expression by hepatocytes can predict the ductopenia grade in primary biliary cholangitis.Keywords
Funding Information
- National Natural Science Foundation of China (81970454, 81970454, 81970454, 81970454)
- Key projects of Jiangsu Provincial Health Commission (ZD2021061)
This publication has 26 references indexed in Scilit:
- Relationship between hepatic progenitor cell‐mediated liver regeneration and non‐parenchymal cellsHepatology Research, 2016
- Contribution of Mature Hepatocytes to Biliary Regeneration in Rats with Acute and Chronic Biliary InjuryPLOS ONE, 2015
- Cytokeratin 7/19 expression in N‐diethylnitrosamine‐induced mouse hepatocellular lesions: implications for histogenesisInternational Journal of Experimental Pathology, 2014
- The expanding significance of keratin intermediate filaments in normal and diseased epitheliaCurrent Opinion in Cell Biology, 2013
- Aberrant cytokeratin 7 expression of centrilobular hepatocytes: a clinicopathological studyHistopathology, 2012
- Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreementPathology International, 2010
- Mechanisms of hepatocyte growth factor–mediated and epidermal growth factor–mediated signaling in transdifferentiation of rat hepatocytes to biliary epitheliumHepatology, 2008
- Interlobular Bile Duct Loss in Pediatric Cholestatic Disease is Associated with Aberrant Cytokeratin 7 Expression by HepatocytesPediatric and Developmental Pathology, 2007
- Antinuclear antibodies giving the ‘multiple nuclear dots’ or the ‘rim‐like/membranous’ patterns: diagnostic accuracy for primary biliary cirrhosisAlimentary Pharmacology & Therapeutics, 2006
- Cytokeratin-7, cytokeratin-19, and c-Kit: Immunoreaction during the evolution stages of primary biliary cirrhosisHepatology Research, 2006